Improving Outcomes with Early Clinical Interventions Enhancing Asthma Patients Health Status and Quality of Life - In Primary Care Settings

The online educational activity contains video and slides from the Allergy, Asthma, and Immunology Section‘s COPD Cluster Session held on July 30, 2016 during the National Medical Association’s 2016 Annual Convention and Scientific Assembly in Los Angeles, CA. This activity was supported in part by educational grants from AstraZeneca, GlaxoSmithKline, Merck & Co.


National Medical Association Annual Convention and Scientific Assembly, 2016

Physician Interdisciplinary Approaches to Improved Care Through Patient-Centered Diagnosis and Treatment

Improving Outcomes with Early Clinical Interventions Enhancing Asthma Patients Health Status and Quality of Life - In Primary Care Settings


Asthma costs in the United States approach $56 Billion dollars each year. The average cost per year for a child with asthma was $1,039 in 2009 with an associated 10.5 million missed days of school. It is common with 1 in 12 adults and 1 in 11 children have asthma. It is deadly with 9 people dying from asthma each day!

Participants should recognize the risk factors for asthma severity, minimize exacerbations, reduce hospital admissions as primary goals of patient care. These sessions will address risk factors for increased asthma severity, how to close the gaps between current care and recommended best practices for the treatment of asthma in primary care settings and working with subspecialties for optimization of best outcomes.

Learning Objectives

At the conclusion of this educational seminar, participants should be able to:

1. Recognize Asthma Guidelines for the treatment of asthma; include the concepts of symptoms and risks into the decision of therapy.
2. Review the concepts of clinical phenotypes as related to the development of and longitudinal asthma risk.
3. Interventions to reduce morbidity and mortality.
4. Outline and identify patients that respond to specific pharmacologic interventions.

Disclosures / Acknowledgement of Financial Support

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose any relevant financial relationships.  An individual has a relevant financial relationship if he or she (or spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.  As an accredited provider balance, independence, objectivity, and scientific rigor must be demonstrated in all educational activities.

The following faculty presenters and planners/managers have stated that they do not have financial relationships or relationships to products or devices with any commercial interests related to the content of this activity during the past 12 months:

Ann Staveren, M.D.

Colin Syphax

Chanda Nicole Holsey, DrPH, MPH

Cherie Y. Zachary, M.D.

Disclosures of Commercial Relationships

The following have listed the entities with whom they have relationships, not necessarily conflicting:  

Rachel Robison, M.D.

Site Co-Investigator: Lurie Children's Hospital for the National Heart Lung and Blood Institute (NHLBI) funded AsthmaNet Clinical Trial Network

Anne Mailand, M.D., Ph.D.

Consultant: Genentech


Employment: University of Colorado, Denver
Financial Interest: Speaker Honoraria - Merck
Data Monitoring Committee: GlaxoSmithKline
Research Interests: NIAID, NIEHS, EPA
Organizational Interests: AAAAI, ATS, AAP, ACAAI

Continuing Education Credits

The National Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The National Medical Association designates this internet enduring activity for a maximum for 1 AMA PRA Category 1 Credit.  Physicians should claim credit commensurate with the extent of their participation in the activity.

Participants must achieve at least 80% correct in the post test evaluation to be awarded credit. 


September 15, 2017


The National Medical Association (NMA) and its staff and consultants, are not responsible for injury or illness resulting from the use of medications or modalities discussed during this educational activity. The NMA does not endorse the use of off-labeled medications. Speakers must identify off-labeled status of any pharmaceuticals mentioned in their lectures.


Sorry, no CME courses were found.